-
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of "Moderate Buy" by Brokerages
ソース: Buzz FX / 13 3 2025 02:56:17 America/New_York
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Celldex Therapeutics, Inc.
Read more...